Xianghong Jasmine Zhou
Directeur Général chez EarlyDiagnostics, Inc.
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Wenyuan Li | M | - |
EarlyDiagnostics, Inc.
 EarlyDiagnostics, Inc. Packaged SoftwareTechnology Services EarlyDiagnostics, Inc. is a company that specializes in developing a blood test called CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. The company is based in Los Angeles, CA. The company offers experimental and computational innovations such as CFSNV, a novel computational tool to accurately call mutations directly from blood, and EarlyDX-Cloud, a "one-stop shop" bioinformatics solution for liquid biopsy. The company was founded in 2017 by Wing H. Wong, Wenyuan Li, Xianghong Jasmine Zhou. Xianghong Jasmine Zhou has been the CEO since 2017. | 7 ans |
| Gregory Critchfield | M | 72 |
EarlyDiagnostics, Inc.
EarlyDiagnostics, Inc. Packaged SoftwareTechnology Services EarlyDiagnostics, Inc. is a company that specializes in developing a blood test called CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. The company is based in Los Angeles, CA. The company offers experimental and computational innovations such as CFSNV, a novel computational tool to accurately call mutations directly from blood, and EarlyDX-Cloud, a "one-stop shop" bioinformatics solution for liquid biopsy. The company was founded in 2017 by Wing H. Wong, Wenyuan Li, Xianghong Jasmine Zhou. Xianghong Jasmine Zhou has been the CEO since 2017. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Wing H. Wong | M | - |
EarlyDiagnostics, Inc.
EarlyDiagnostics, Inc. Packaged SoftwareTechnology Services EarlyDiagnostics, Inc. is a company that specializes in developing a blood test called CancerRadar, which is highly accurate and sensitive in detecting and locating cancer. The company is based in Los Angeles, CA. The company offers experimental and computational innovations such as CFSNV, a novel computational tool to accurately call mutations directly from blood, and EarlyDX-Cloud, a "one-stop shop" bioinformatics solution for liquid biopsy. The company was founded in 2017 by Wing H. Wong, Wenyuan Li, Xianghong Jasmine Zhou. Xianghong Jasmine Zhou has been the CEO since 2017. | - |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 3 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Xianghong Jasmine Zhou
- Réseau Personnel
